Catheter-based renal sympathetic denervation is effective in reducing office and ambulatory blood pressure in patients with resistant hypertension

International Journal of Cardiology

Volumn 172, Issue 1, 2014, Pages 259-260

  Liu, Mao ^a   Chen, Jian ^a   Liu, Changzhi ^a   Huang, Dan ^a   Ke, Jianting ^a   Tang, Wenyi ^a   Huang, Suihua ^a   Wu, Wei ^a  

^a THE FIFTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Hypertension; Meta analysis; Renal sympathetic denervation

Indexed keywords

BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CATHETER; CLINICAL EFFECTIVENESS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; HUMAN; KIDNEY DENERVATION; LETTER; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRESSORECEPTOR; PRIORITY JOURNAL; QUALITY CONTROL; RESISTANT HYPERTENSION; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; HYPERTENSION, RENAL; META ANALYSIS; PROCEDURES; SYMPATHECTOMY; TREATMENT OUTCOME;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYPERTENSION, RENAL; SYMPATHECTOMY; TREATMENT OUTCOME;

EID: 84894101867     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.12.267     Document Type: Article

References (19)

1. H. Krum, M. Schlaich, and R. Whitbourn et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study Lancet 373 2009 1275 1281
2. L. Wang, C.Z. Lu, and X. Zhang et al. The effect of catheter based renal synthetic denervation on renin-angiotensin-aldosterone system in patients with resistant hypertension Zhonghua Xin Xue Guan Bing Za Zhi 41 2013 3 7
3. B. Kaltenbach, J. Franke, and S.C. Bertog et al. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study Catheter Cardiovasc Interv 81 2013 335 339
4. M.D. Esler, H. Krum, and P.A. Sobotka et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 Trial): a randomised controlled trial Lancet 376 2010 1903 1909
5. E. Pokushalov, A. Romanov, and G. Corbucci et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension J Am Coll Cardiol 60 2012 1163 1170
6. M.D. Esler, H. Krum, and M. Schlaich et al. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 Randomized, Controlled Trial Circulation 126 2012 2976 2982
7. T. Mabin, M. Sapoval, and V. Cabane et al. First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension EuroIntervention 8 2012 57 61
8. M. Voskuil, W.L. Verloop, and P.J. Blankestijn et al. Percutaneous renal denervation for the treatment of resistant essential hypertension; the first Dutch experience Neth Heart J 19 2011 319 323
9. C. Ukena, F. Mahfoud, and A. Spies et al. Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension Int J Cardiol 167 2013 2846 2851
10. A. Witkowski, A. Prejbisz, and E. Florczak et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea Hypertension 58 2011 559 565
11. D. Hering, F. Mahfoud, and A.S. Walton et al. Renal denervation in moderate to severe CKD J Am Soc Nephrol 23 2012 1250 1257
12. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension, 2011, 57:911-917.
13. C.S. Zuern, K.D. Rizas, and C. Eick et al. Effects of renal sympathetic denervation on 24-hour blood pressure variability Front Physiol 3 2012 134
14. S.G. Worthley, C.P. Tsioufis, and M.I. Worthley et al. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I Trial Eur Heart J 34 2013 2132 2140
15. H. Ahmed, P. Neuzil, and J. Skoda et al. Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension JACC Cardiovasc Interv 5 2012 758 765
16. H. Vase, O.N. Mathiassen, and A. Kaltoft et al. Catheter-based renal denervation for treatment of resistant hypertension Dan Med J 59 2012 A4439
17. B. Damascelli, G. Patelli, and V. Ticha et al. Catheter-based radiofrequency renal sympathetic denervation for resistant hypertension J Vasc Interv Radiol 24 2013 632 639
18. D. Prochnau, H.R. Figulla, and R. Surber Efficacy of renal denervation with a standard EP catheter in the 24-h ambulatory blood pressure monitoring-long-term follow-up Int J Cardiol 157 2012 447 448
19. M.I. Davis, K.B. Filion, and D. Zhang et al. Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis J Am Coll Cardiol 62 2013 231 241